Congress Denies FDA’s Call for Mandatory Oversight of Compounding Pharmacies

Washington Drug Letter
A A
Congress rejected the FDA’s call for mandatory oversight of compounding pharmacies, passing legislation Nov. 18 that instead allows compounders to volunteer for agency oversight.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00